Underweight: Trim 40-45% SPCX via phased three-tranche execution as binary catalysts cluster within 2-4 weeks
Underweight with committed trim action—not Hold—per 2026-08-12 mandate requiring explicit trim language when statistical mean-reversion probability is elevated and binary event is within 24-48 hours. Residual position capped at ≤50% of prior allocation preserves convexity while reducing asymmetric downside risk from 75x forward P/E with three lower highs into 50 SMA at $141.85. Own less of this name, not zero; wait for verified proof of AI/Starship thesis (successful Starship catch + hold above $148 on volume) or multiple compression to justifiable level (close below $108 with structural failure) before adding.
| Position | Action |
|---|---|
| Price rallies to $144-146 (relief rally) | Trim 15% of SPCX exposure (tranche #1) |
| Lockup unlock event | Trim 10-15% of SPCX exposure (tranche #2) |
| Starship catch catalyst | Trim 10-15% of SPCX exposure (tranche #3) |
| 50 SMA fails as resistance and price closes below 10 EMA at $130.90 | Further cut residual (contingent) |
| Price closes below $108 on >150M volume with RSI <40 | Hard exit entire position |
SpaceX is approaching an earnings inflection that will make current valuation appear cheap; the bear's static analysis of negative earnings and high P/E ignores the 94% operating income improvement trajectory, 650bps gross margin expansion, and $93.5B cash fortress.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 130.90 | bullish |
| 50 SMA | 141.85 | neutral |
| 200 SMA | 141.85 | neutral |
| RSI | 55.58 | neutral |
| MACD | -0.18 | bullish |
| MACD Signal | -4.60 | bullish |
| MACD Histogram | +4.42 | bullish |
| Bollinger Upper | 144.13 | neutral |
| Bollinger Middle (20 SMA) | 121.73 | neutral |
| Bollinger Lower | 99.33 | neutral |
| ATR | 10.81 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price reaches $115-120 with RSI reset below 40
Then: Higher-probability reentry point per distribution pattern
· concedes: Bear's concern about 75x forward P/E is understandable on a static basis, but this is a delayed-gratification asset pricing in Starship commercialization, Starlink monetization, defense contracts, and AI compute optionality; Bear's concern about negative earnings is valid for trailing periods but ignores the undeniable trajectory of improvement; Bear's technical concerns about the 50 SMA resistance are valid in the short term, but the 10 EMA dynamic support and imminent Starship catalyst should break the compression
SPCX is a SELL/AVOID into strength, not a BUY into weakness. The technical "coiled spring" has already broken (price rejected 50 SMA, volume fading, lower-highs in place), the balance sheet is a dilution-funded burn rate with only 14-18 months of runway, the Starship catalyst is symmetrical ~50/50 risk, and sentiment is approaching euphoria at a single-quarter-old IPO—making this a distribution opportunity inside a bear market rally.
· concedes: Long-dated thesis (Starship, Starlink, AI compute) is real but already priced at $1.85T equity value; Q2 2026 operating income improvement is real (-$141M vs -$775M YoY); Q2 2026 revenue growth +66.5% Q/Q is a strong print
→ vs conservative: Waiting for daily close above 50 SMA at 144 is too late—by then you're buying the exact top that 144 has marked in three separate sessions (August 12: 146, August 13: 145.02, August 14: 144.02)
→ vs conservative: The 'do nothing' stance leaves the position exposed to a Starship failure that would single-handedly compress valuation 20-30%
→ vs conservative: At $10 ATR and 9% intraday swings, waiting for 'confirmation' means getting steamrolled in asymmetric setups
→ vs neutral: The neutral 'hold and see' stance means becoming a forced seller into any gap down because no trim was executed; passive in this setup is the riskiest position
→ vs neutral: The 'structural trend confirmation' argument ignores that MACD bullish crossover already triggered on August 8-12 and RSI recovered from 28 to 55—the rebound already happened
→ vs neutral: The 'balance sheet fortress' thesis ignores that $85.7B of the $93.5B cash came from freshly printed shares, not organic cash flow
→ vs neutral: The '$906B insider stake' is anchoring on a number disclosed at the peak; insider value can evaporate when float thins and macro deteriorates
Support: 130 · 131 · 125.33 · 121.73 · 108.37 | Resistance: 141.85 · 144.13 · 146.15 · 149.6 · 170
SPCX has shifted short-term bullish after reclaiming the 10 EMA (130.90), with MACD issuing a fresh bullish crossover (histogram +4.42, MACD at -0.18) and RSI recovering from oversold (28.3) to neutral (55.6). However, the 50 SMA at 141.85 remains unreclaimed and is acting as immediate resistance. The 141-144 zone is the critical decision point: a confirmed daily close above 144 on volume would favor continuation toward 149-170, while rejection would likely pull price back to 121-131 first. ATR has compressed to 10.81 (down ~65% from June's ~30), indicating lower but still elevated volatility, warranting ATR-based stops (~16 points) and conservative position sizing.
Market Cap
$1.845T
52-Week High
$225.64
52-Week Low
$104.83
50-Day/200-Day Average
~$141.85
Shares Outstanding
~13.18B
Book Value per Share
$9.656
Forward P/E
75.56x
Price/Book
14.5x
FY2023 Revenue
$10.387B
FY2024 Revenue
$14.015B
FY2025 Revenue
$18.674B
Revenue YoY 2024→2025
+33.2%
Gross Margin FY2023
41.2%
Gross Margin FY2024
42.9%
Gross Margin FY2025
49.4%
Q1 2026 Revenue
$4.694B
Q2 2026 Revenue
$7.814B
Q2 2026 Revenue Q/Q
+66.5%
H1 2026 Revenue
$12.508B
Operating Income FY2023
$0.507B
Operating Income FY2024
$0.742B
Operating Income FY2025
-$2.064B
Operating Margin TTM
-1.8%
EBITDA FY2023
-$0.663B
EBITDA FY2024
$5.646B
EBITDA FY2025
$4.427B
Net Income FY2023
-$4.628B
Net Income FY2024
$0.791B
Net Income FY2025
-$4.937B
Net Income TTM
-$8.889B
Profit Margin TTM
-35.7%
Diluted EPS FY2023
-$0.436
Diluted EPS FY2024
$0.002
Diluted EPS FY2025
-$0.51
TTM EPS
-$1.10
Forward EPS
$1.85
R&D Expense FY2023
$2.105B
R&D Expense FY2024
$3.464B
R&D Expense FY2025
$8.643B
R&D % Revenue FY2025
46.3%
SG&A FY2023
$1.665B
SG&A FY2024
$1.813B
SG&A FY2025
$2.644B
Total Assets Q2 2026
$192.770B
Total Debt Q2 2026
$39.708B
Cash & Equivalents Q2 2026
$93.522B
Stockholders' Equity Q2 2026
$127.224B
Working Capital Q2 2026
$86.925B
Current Ratio TTM
5.115
Debt to Equity TTM
31.2
PP&E FY2025
$43.862B
PP&E Q2 2026
$66.854B
Depreciation FY2025
$6.701B
Operating CF FY2023
$4.520B
Operating CF FY2024
$5.776B
Operating CF FY2025
$6.785B
Capex FY2023
-$4.415B
Capex FY2024
-$11.163B
Capex FY2025
-$20.906B
Capex % Revenue FY2025
112%
Free Cash Flow FY2023
$0.105B
Free Cash Flow FY2024
-$5.387B
Free Cash Flow FY2025
-$14.121B
End Cash FY2023
$4.690B
End Cash FY2024
$11.501B
End Cash FY2025
$25.124B
Interest Expense FY2024
$1.580B
Interest Expense FY2025
$1.945B
Q2 2026 Operating Income
-$141M
Q2 2026 Net Income
-$541M
Q2 2026 EPS
-$0.09
Q2 2026 R&D
$3.548B
Common Stock Issued Q2 2026
+$85.675B
Strengths
Concerns
SPCX is a mega-cap aerospace company with FY2025 revenue of $18.674B growing 33.2% YoY, though it posted a net loss of -$4.937B due to aggressive investment in R&D ($8.643B) and capex ($20.906B). The company completed a massive $85.675B equity raise in Q2 2026, ending with $93.522B in cash and a fortress balance sheet, while operations are approaching breakeven with Q2 2026 operating income of just -$141M. The stock trades near its 52-week high with a premium forward P/E of 75.56x, reflecting market confidence in future profitability from Starlink, Starship, and defense programs.
Macro: Risk-on supportive but softening at the margin. Fed on hold per 85% market-implied probability of zero cuts in 2026; weak July retail sales dented hopes for rate activity. US recession odds at just 8% by end-2026 (down 0.5pp WoW), Japan at 26%, UK at 10%. Oil prices rallied providing inflationary pushback. VIX regime shows bifurcated tone with risk-on trades still leading but cautious trading evident.